Metronidazole appears not to be a human teratogen: Review of literature
β Scribed by Barbara J. Struthers
- Publisher
- Hindawi Publishing Corporation
- Year
- 1997
- Tongue
- English
- Weight
- 72 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1064-7449
No coin nor oath required. For personal study only.
β¦ Synopsis
Metronidazole is used to treat trichomoniasis, bacterial vaginosis, and other diseases. As is the case with many drugs, physicians often hesitate to use it during pregnancy, particularly in the first trimester. A review of the nearly four decades' worth of published literature on metronidazole use in pregnant women indicates that it is not teratogenic, regardless of the trimester in which it is used. On the other hand, a number of published studies indicate that bacterial vaginosis and trichomoniasis are associated with preterm birth and low birth weight. Treatment of these conditions with metronidazole during pregnancy may decrease the incidence of preterm birth and low birth weight, thus potentially decreasing the complications that can result from prematurity.
π SIMILAR VOLUMES
Different models have been proposed to explain lineage commitment in hemopoiesis. Some suggest that lineage commitment occurs in a stochastic manner without the direct influence of extracellular factors; others postulate that cytokines determine whether multipotent cells will become erythroid or gra
## Abstract Root cause analysis is perhaps the most widely used tool in healthcare risk management, but does it actually lead to successful risk control? Are there categories of risk control that are more likely to be effective? And do healthcare risk managers have the tools they need to support th
Writing good titles is a crucial part of optimising articles' chances of being peer reviewed, and later found in the literature via Google: here are some tips. . .